Literature DB >> 32200811

Prevalence of Age-related Maculopathy: The Beaver Dam Eye Study.

Ronald Klein1, Barbara E K Klein1, Kathryn L P Linton1.   

Abstract

PURPOSE: The relationships of retinal drusen, retinal pigmentary abnormalities, and macular degeneration to age and sex were studied in 4926 people between the ages of 43 and 86 years who participated in the Beaver Dam Eye Study.
METHODS: The presence and severity of various characteristics of drusen and other lesions typical of age-related maculopathy were determined by grading stereoscopic color fundus photographs using the Wisconsin Age-Related Maculopathy Grading System.
RESULTS: One or more drusen were present in the macular area of at least 1 eye in 95.5% of the population. People 75 years of age or older had significantly higher frequencies (P < 0.01) of the following characteristics than people 43 to 54 years of age: larger sized drusen (>125 /μm, 24.0% versus 1.9%), soft indistinct drusen (23.0% versus 2.1%), retinal pigment abnormalities (26.6% versus 7.3%), exudative macular degeneration (5.2% versus 0.1%), and geographic atrophy (2.0% versus 0%).
CONCLUSION: These data indicate signs of age-related maculopathy are common in people 75 years of age or older and may pose a substantial public health problem.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2020        PMID: 32200811     DOI: 10.1016/j.ophtha.2020.01.033

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  5 in total

1.  Prevalence of age-related macular degeneration among optometric telemedicine users in Spain: a retrospective nationwide population-based study.

Authors:  Miguel A Zapata; Anniken Burés; Roberto Gallego-Pinazo; Estanislao Gutiérrez-Sánchez; Andrea Oléñik; Salvador Pastor; Jorge Ruiz-Medrano; Cecilia Salinas; Susana Otero-Romero; Maximino Abraldes
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-02-12       Impact factor: 3.117

2.  Exploration of the Effect and Mechanism of Fructus Lycii, Rehmanniae Radix Praeparata, and Paeonia lactiflora in the Treatment of AMD Based on Network Pharmacology and in vitro Experimental Verification.

Authors:  Xi Chen; Jing Zuo; Tianming Hu; Xiaoqing Shi; Yujie Zhu; Hao Wu; Ying Xia; Wei Shi; Wei Wei
Journal:  Drug Des Devel Ther       Date:  2021-06-28       Impact factor: 4.162

Review 3.  Complement System and Potential Therapeutics in Age-Related Macular Degeneration.

Authors:  Young Gun Park; Yong Soo Park; In-Beom Kim
Journal:  Int J Mol Sci       Date:  2021-06-25       Impact factor: 5.923

Review 4.  Neovascular Age-Related Macular Degeneration: Therapeutic Management and New-Upcoming Approaches.

Authors:  Federico Ricci; Francesco Bandello; Pierluigi Navarra; Giovanni Staurenghi; Michael Stumpp; Marco Zarbin
Journal:  Int J Mol Sci       Date:  2020-11-03       Impact factor: 5.923

5.  Economic burden of age-related macular degeneration in routine clinical practice: the RAMDEBURS study.

Authors:  José M Ruiz-Moreno; Luís Arias; Maximino J Abraldes; Javier Montero; Patricia Udaondo
Journal:  Int Ophthalmol       Date:  2021-06-10       Impact factor: 2.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.